论文部分内容阅读
自发现鼻咽癌病人血清及唾液中存在抗EB病毒各种抗原的抗体以来,迄今为止能够提供鼻咽癌血清学临床诊断或现场普查具有实用价值的仍为测定EBV-VCA或EBV-EA抗体的手段。本文报告鼻咽癌病人血清中抗EB病毒VCA-IgM抗体的存在。 材料和方法 (一)受检血清标本 50例鼻咽癌病人血清取自本院或北京医院病人。100例正常人血清取自天坛医院血库及血站的献血员。53例其他肿瘤病人血清取自本院临床生化室。 (二)马抗人IgM抗体来源及制备
Since the discovery of antibodies against various Epstein-Barr virus antigens in serum and saliva of patients with nasopharyngeal carcinoma, it has so far been possible to provide sera for clinical diagnosis or on-site screening of nasopharyngeal carcinoma with practical value for determination of EBV-VCA or EBV-EA antibodies. s method. This report reports the presence of anti-EB virus VCA-IgM antibodies in nasopharyngeal carcinoma patients. Materials and Methods (I) Serum samples to be tested 50 cases of nasopharyngeal cancer patients were taken from patients in this hospital or Beijing hospital. 100 normal blood serums were taken from blood donors and blood stations of the Tiantan Hospital. The serum of 53 patients with other tumors was taken from the clinical biochemistry room of this hospital. (B) Horse anti-human IgM antibody source and preparation